Insider Sale: CEO at HCAT sold 35,244 Shares

Albert Benjamin, chief executive officer at Health Catalyst (NASDAQ: HCAT), divested 35,244 shares of the company on Sep 10, 2026 for an estimated $59,023. The transaction represented roughly 2.5% of their holdings in this stock class. Post-trade, Benjamin’s position stands at 1,388,406 shares of HCAT stock.

Health Catalyst Insider Trading Activity

Health Catalyst insiders have traded HCAT stock on the open market 0 times in the past 6 months. Of those trades, 0 have been purchases and 0 have been sales.

Here’s a breakdown of recent trading of HCAT stock by insiders over the last 6 months:

Health Catalyst Revenue

Health Catalyst had revenues of $141.2M in H1 2026. This represents a 11.80% decrease from the same period last year.